Objective: To summarize evidence on the rates and drivers of progression from
normoglycemia to prediabetes and/or diabetes mellitus (hereafter “diabetes”) in antiretroviral …

Antiretroviral therapy has revolutionized the care of people with human immunodeficiency
virus (HIV) by reducing morbidity and mortality from acquired immunodeficiency syndrome …

Background Data on the burden of dyslipidaemia among people with HIV undergoing
antiretroviral therapy (ART) in sub-Saharan Africa are limited and little is known about the …

Background. The application of nanomedicine to antiretroviral drug delivery holds promise
in reducing the comorbidities related to long‐term systemic exposure to highly active …

HIV-associated cerebrovascular events remain highly prevalent even in the current era of
antiretroviral therapy (ART). We hypothesize that low-level HIV replication and associated …

The introduction of antiretroviral drugs (ARVd) changed the prognosis of HIV infection from a
deadly disease to a chronic disease. However, even with undetectable viral loads, patients …

Introduction Despite growing enthusiasm for integrating treatment of non‐communicable
diseases (NCDs) into human immunodeficiency virus (HIV) care and treatment services in …

Background Long-term antiretroviral therapy has modified the clinical course of HIV infection
to a chronic condition associated with increased risk of developing non-communicable …

Background It is unknown whether statin use among people living with HIV results in a
reduction in all-cause mortality. We aimed to evaluate the effect of statin use on all-cause …

Although more than one in two HIV-infected persons may develop central fat accumulation
soon after commencing antiretroviral therapy, the association between antiretroviral therapy …